Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program - Wikidata - awgldk - TriplyDB

Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program

Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program

http://www.wikidata.org/entity/Q34343779

about

SLE: Another Autoimmune Disorder Influenced by Microbes and Diet?I too, am America: a review of research on systemic lupus erythematosus in African-Americans Association between Toll-Like Receptor 4 Polymorphisms and Systemic Lupus Erythematosus Susceptibility: A Meta-Analysis Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy Healthcare burden of depression in adults with arthritis.Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis.The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.Splenectomy increases the subsequent risk of systemic lupus erythematosus.Cholinergic agonists reduce blood pressure in a mouse model of systemic lupus erythematosus.Rheumatic autoimmune diseases in women and midlife health Diminished white matter integrity in patients with systemic lupus erythematosus.Is pregnancy a risk factor for rheumatic autoimmune diseases?Environmental influences on systemic lupus erythematosus expression Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies Belimumab for the treatment of systemic lupus erythematosus.Gastrointestinal symptom due to lupus peritonitis: a rare form of onset of SLE ESRD from lupus nephritis in the United States, 1995-2010 Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011.Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States: NHANES.Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus Effect of Systemic Lupus Erythematosus on the Risk of Incident Respiratory Failure: A National Cohort Study Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007-2009.Ethnicity-specific epigenetic variation in naïve CD4+ T cells and the susceptibility to autoimmunity.Improving a full-text search engine: the importance of negation detection and family history context to identify cases in a biomedical data warehouse.Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products The frequency and outcome of lupus nephritis: results from an international inception cohort study.Pregnancy and autoimmune connective tissue diseases Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus.Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between immunofluorescence and multiplex assays.Presentation of SLE in UK primary care using the Clinical Practice Research Datalink.Spatial environmental modeling of autoantibody outcomes among an African American population.Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.Evaluation of epratuzumab as a biologic therapy in systemic lupus erythematosus.

P2860

Q26773130-8EEC204E-431C-4040-8181-1A0D2FFD2B8B Q28069750-0A824FD3-9662-4F95-93DA-4DCE5246A3B6 Q28073647-51C08ED3-8620-46CF-80A8-08DF2420B7E2 Q28607141-40C99D46-195C-4646-B970-A992517FB3ED Q28651110-C19B599C-C2E4-40CA-B362-4C0EA65BFDCB Q30238991-49726A80-3280-41B6-835F-BE0F9969E06B Q30248879-4B373570-E7EA-4980-B0BE-096568294AFA Q33425674-18533920-772F-41AA-876B-83456CFE663A Q33427267-3F7EEABA-9153-4F8C-B060-28D408FD7E3F Q33567470-E4578F3C-F56F-4909-BB1A-0F9CBF4FF0AB Q33727015-2E783B2D-6194-4E44-98CB-197A6415FAB2 Q34079262-4B2322C1-151D-49FA-BB0F-CC321D19EBC0 Q34118068-C28B594B-AF0A-4245-A229-2A580E8D1AA0 Q34344835-AA89CEBA-03F6-47E0-8208-B5A1752872D6 Q34424615-B6F77D03-0130-4EC9-995E-7D565A231BF5 Q34455827-0B70C895-8FAA-4A9E-ACE8-6609BA37F5A8 Q35017516-DE1C1C49-30CC-4746-861E-246F0732AC38 Q35051164-2E993B65-11B2-4795-B781-E5DC15A30EED Q35195820-9E7D7374-C638-41ED-A6D1-68E80FC102AC Q35567251-50189BC8-C667-46E7-A7B8-6B540B585FFE Q35761089-18BE6247-E5E5-4D55-A578-91290ABF09F8 Q35893859-57671CF8-CC91-40C6-BC53-5C68D48A79A6 Q35928011-CE79D1B5-0DDA-4D24-8BBB-C6A9E1D072DD Q35961658-AA4EC4B1-771C-418B-B115-373DD1877538 Q36139802-FB512B53-851D-4403-B832-B989ABF0B678 Q36198950-6B1FCD4D-8793-4569-BE01-FD50DCC1642D Q36318330-B0877EEF-35E9-426D-BE7B-C1045EB2640D Q36322199-4811F212-D7D5-467E-BA1B-3D00A91E7A38 Q36373157-B6EB1657-6480-4A24-9255-3266656FF936 Q36540787-C1712832-02E4-4BEC-9E2A-F6435F07E715 Q36559699-389EDDB4-BA28-4956-AF16-FF0612B09887 Q37082037-2721F47D-A6FD-401E-B6C6-0ADD43BBE53C Q37100267-47D4812F-B64C-4DAB-BD6A-04384728CC62 Q37334183-BDCDBF49-067E-47B6-B92D-DD7EFEE0A9C5 Q37402771-70FD45FA-3779-49AC-A60E-00E0134A80C6 Q37538473-F0CA9FBC-77C3-46ED-9198-8AEB920C3D5D Q37640274-8984EAE1-304F-4ACA-8E31-109330A1CBD9 Q37703233-CAB600E0-B556-4C2A-BDAE-E2974663E053 Q38247180-4B8FB2C9-73DF-48B7-9A25-8DED6DDB0B2A Q38286372-E8ADDA40-23C0-4089-9869-AF628DB918C3

P2860

Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program

http://www.wikidata.org/entity/Q34343779

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Population-based incidence and ...... ology and Surveillance program

@ast

Population-based incidence and ...... ology and Surveillance program

@en

Population-based incidence and ...... ology and Surveillance program

@nl

type

label

Population-based incidence and ...... ology and Surveillance program

@ast

Population-based incidence and ...... ology and Surveillance program

@en

Population-based incidence and ...... ology and Surveillance program

@nl

prefLabel

Population-based incidence and ...... ology and Surveillance program

@ast

Population-based incidence and ...... ology and Surveillance program

@en

Population-based incidence and ...... ology and Surveillance program

@nl

P1433

Q34343779-3326D19C-55A5-4338-B649-A486DE1E7EC9

P1476

Q34343779-8E6EE7A2-5F63-4C64-90F4-113CB3985EC3

P2093

Q34343779-1C674780-FC8B-4417-B0B1-B472B1F60B53

Q34343779-1C758529-BC94-49C3-8BCB-5DAA3C660223

Q34343779-2854CC8F-554D-4B6E-A484-64C351CE5094

Q34343779-4511E373-7862-4AAD-8D72-AC5428452E91

Q34343779-4FC9BD0D-8B00-4D16-B238-376C5087A1A6

Q34343779-7FC4BC2F-7C11-4BD6-8BEC-8784ED2DE850

Q34343779-8E922D32-6AA2-4BF8-BB5A-9F500ADE57C0

Q34343779-90ED7A81-944A-4990-B737-EF43A972866C

Q34343779-D36BCEB2-EC46-4C88-AAEB-02BBFA431B4B

Q34343779-E74E98E1-74A0-49FA-9909-D5766959A70F

P2860

Q34343779-23929DD8-302D-452F-84E3-D8987ACD14FE

Q34343779-25002331-213B-45C4-90DA-DE535B3DE221

Q34343779-2699FBC0-B251-4434-9525-0B7993AEC242

Q34343779-34AAC117-6DCF-40CA-B0FE-825D60025B53

Q34343779-3EE5B1E6-BE3A-4ED1-945E-443A7F370A67

Q34343779-4ED29B9C-BA03-48DA-B90F-4F82BC85BEB4

Q34343779-4F97C2F8-1170-4111-8081-0BB4EB76B5D4

Q34343779-52D5D713-8D14-457D-BDF4-4CBADB1B94F0

Q34343779-5330C290-D0DB-456D-8684-D95D08731915

Q34343779-67D55986-4990-4A6A-AD45-0F2066886D68

P304

Q34343779-376192D9-A91C-4C26-9870-8DBF905149D2

P31

Q34343779-22DFDA40-D0DE-47B8-A9C5-C9615CF25E1A

P356

Q34343779-02AA345A-845C-4AE5-8180-D19578F4323C

P433

Q34343779-8DF5977E-D6DD-4CAB-B098-4B9D04CC8704

P478

Q34343779-7673395B-E24A-44BB-9E0F-E28813880DEE

P50

Q34343779-35189EAD-2C4F-42F7-8028-271231A8AB21

Q34343779-99AEFC67-7F57-4A47-B355-48CE118F543F

P577

Q34343779-3A5B7938-903B-45B6-8A61-2AFFD98ADAB7

P5875

Q34343779-B7E66A5F-8AE0-40DD-BFCF-05A1662B0B0E

P698

Q34343779-C1036558-1B92-4E5A-8AAE-F5AACB360B94

P921

Q34343779-576444A3-42EE-4D92-AFFA-1F06D55A9B30

P932

Q34343779-697AD508-51BF-4FBE-B7E9-FB0CD716C116

P356

P1433

Arthritis & Rheumatology

P1476

Population-based incidence and ...... ology and Surveillance program

@en

P2093

Charles G Helmick

http://www.w3.org/2001/XMLSchema#string

Diane Shaltis

http://www.w3.org/2001/XMLSchema#string

Emily E Lewis

http://www.w3.org/2001/XMLSchema#string

J Patricia Dhar

http://www.w3.org/2001/XMLSchema#string

James Leisen

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Wing

http://www.w3.org/2001/XMLSchema#string

Lu Wang

http://www.w3.org/2001/XMLSchema#string

Patricia Cagnoli

http://www.w3.org/2001/XMLSchema#string

Peter DeGuire

http://www.w3.org/2001/XMLSchema#string

W Joseph McCune

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating the Dimension of a Model

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

A population-based assessment of systemic lupus erythematosus incidence and prevalence--results and implications of using administrative data for epidemiological studies.

Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients.

Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004

Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases

Measurement of systemic lupus erythematosus activity in clinical research.

Incidence of systemic lupus erythematosus. Race and gender differences.

P304

369-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.38238

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Gordon

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258116198

http://www.w3.org/2001/XMLSchema#string

P698

24504809

http://www.w3.org/2001/XMLSchema#string

P921

P932

4198147

http://www.w3.org/2001/XMLSchema#string